Barrington Research Comments on Henry Schein Q3 Earnings

Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at Barrington Research lifted their Q3 2025 earnings per share estimates for shares of Henry Schein in a note issued to investors on Wednesday, February 26th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $1.30 for the quarter, up from their prior estimate of $1.22. Barrington Research currently has a “Outperform” rating and a $90.00 target price on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share.

Several other brokerages also recently commented on HSIC. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Mizuho started coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target on the stock. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. UBS Group reduced their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday. Finally, Wells Fargo & Company began coverage on Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price on the stock. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Stock Down 0.6 %

Shares of NASDAQ:HSIC opened at $72.12 on Friday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock’s 50-day moving average price is $74.35 and its 200-day moving average price is $72.42. The stock has a market capitalization of $8.99 billion, a P/E ratio of 29.68, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same quarter in the previous year, the company posted $0.66 earnings per share. Henry Schein’s revenue for the quarter was up 5.8% compared to the same quarter last year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Palestra Capital Management LLC bought a new position in shares of Henry Schein during the 4th quarter valued at approximately $182,988,000. Lyrical Asset Management LP purchased a new position in shares of Henry Schein in the fourth quarter valued at about $126,655,000. Norges Bank bought a new position in shares of Henry Schein in the fourth quarter worth about $103,301,000. Steadfast Capital Management LP grew its position in shares of Henry Schein by 254.2% during the fourth quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock worth $113,336,000 after purchasing an additional 1,175,408 shares in the last quarter. Finally, ING Groep NV bought a new stake in Henry Schein during the 3rd quarter valued at approximately $63,226,000. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.